Measure emotional response to music
- Trial ID
- NCT06688968
- Official Title
- Observational Pilot Study of Neuropsychological Profiles and Musical Engagement in Parkinson's and Alzheimer's Disease. What Are the Effects of Mnestic or Hedonic Impairment on Emotion, Reminiscence and Musical Enjoyment
- Goal
- Measure emotional response to music
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- University Hospital, Montpellier
- Study Type
- INTERVENTIONAL
- Enrollment
- 120 participants
- Conditions
- Alzheimer Disease, Early Onset, Parkinsons Disease with Dementia, Non Pharmacological Intervention
- Interventions
- neuropsychologist interview, questionnaire
Summary For Families
The goal is to figure out how memory loss or a reduced ability to feel pleasure in Parkinson’s disease with dementia (and early Alzheimer’s) changes emotional reactions, reminiscence, and enjoyment of music, information that can help shape music-based support. The approach uses structured neuropsychological interviews and questionnaires to map cognitive and hedonic profiles and to measure emotional and memory responses to musical engagement, so no drugs or devices are given. The study is looking for French-speaking adults age 60 and up who live at home with a relative, have an MMSE score of 20 or higher, and a diagnosis of idiopathic Parkinson’s disease or probable Alzheimer’s disease; people with major non-degenerative neurological or psychiatric disorders, untreated hearing loss, inability to consent, or recent stroke/head trauma are excluded. The pilot plans to enroll about 120 participants.
Locations
- Montpellier Seniors' Association, Montpellier, Hérault, France
- CHU de Montpellier - CEPMo, Montpellier, Hérault, France
- CHU de Montpellier - CMRR, Montpellier, Hérault, France
Frequently Asked Questions
- What is this trial testing?
- This trial is studying neuropsychologist interview. The goal is to figure out how memory loss or a reduced ability to feel pleasure in Parkinson’s disease with dementia (and early Alzheimer’s) changes emotional reactions, reminiscence, and enjoyment of music, information that can help shape music-based support. The approach uses structured neuropsychological interviews and questionnaires to map cognitive and hedonic profiles and to measure emotional and memory responses to musical engagement, so no drugs or devices are given. The study is looking for French-speaking adults age 60 and up who live at home with a relative, have an MMSE score of 20 or higher, and a diagnosis of idiopathic Parkinson’s disease or probable Alzheimer’s disease; people with major non-degenerative neurological or psychiatric disorders, untreated hearing loss, inability to consent, or recent stroke/head trauma are excluded. The pilot plans to enroll about 120 participants.
- Who can participate?
- Participants must be at least 60 Years.
- Where is this trial located?
- This trial is recruiting at 3 locations.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 10 months.
- Will I get the real drug or a placebo?
- It depends on the trial design. Some Parkinson's trials are placebo controlled, meaning a portion of participants get an inactive comparison while others get the experimental treatment. Some use crossover designs so everyone eventually receives the active treatment at some point. Observational trials do not use a placebo at all because they are not testing a new treatment. The consent form for any specific trial spells out the design and your odds of being assigned to placebo before you enroll.
- How often will I need to visit the study site?
- Visit frequency varies by trial. Many Parkinson's studies require an in person visit every 4 to 12 weeks during the active treatment phase, with shorter or longer gaps depending on the design. The site coordinator can give you the full visit schedule before you sign anything, so you know what the time commitment looks like.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Will travel or parking be reimbursed?
- Many trials reimburse for parking, mileage, and sometimes lodging if the site is far from your home. Reimbursement policies vary by sponsor and site. When you contact the trial team, ask specifically what is covered and how reimbursement is processed.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.